Stay updated with breaking news from Nasdaq Proc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Procaps Group (NASDAQ:PROC – Get Rating) is one of 891 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its competitors? We will compare Procaps Group to similar companies based on the strength of its analyst recommendations, institutional ownership, dividends, risk, earnings, valuation and profitability. Profitability This table compares Procaps Group […]
Procaps Group (NASDAQ:PROC – Get Rating) posted its quarterly earnings data on Monday. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.11, reports. Procaps Group had a net margin of 8.01% and a negative return on equity of 233.90%. The company had revenue of $84.16 […]
Procaps Group S.A. (NASDAQ:PROC – Get Rating) was the recipient of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 103,600 shares, a drop of 14.2% from the April 30th total of 120,700 shares. Approximately 0.5% of the shares of the stock are short […]
Procaps Group S.A. (NASDAQ:PROC – Get Rating) – Investment analysts at Brookline Capital Management decreased their Q3 2023 earnings per share estimates for shares of Procaps Group in a research note issued to investors on Tuesday, May 16th. Brookline Capital Management analyst K. Dolliver now anticipates that the company will earn $0.13 per share for […]
Procaps Group S.A. (NASDAQ:PROC – Get Rating) shares gapped up before the market opened on Monday . The stock had previously closed at $4.40, but opened at $4.81. Procaps Group shares last traded at $4.81, with a volume of 891 shares traded. Procaps Group Stock Down 0.5 % The firm’s fifty day simple moving average […]